ACM
NDRA icon

Altium Capital Management’s ENDRA Life Sciences NDRA Stock Holding History

Altium Capital Management’s Portfolio NDRA Stock Details NDRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$241K Hold
51,900
– – 0.57% 19
2025
Q4 		$235K Buy
+51,900
New +$296K 0.93% 17

Other funds holding NDRA

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $541M AUM 1,009.51% 1-Year Est. Return

Altium Capital Management's NDRA Position: Q1 2026 in Review

Altium Capital Management held its ENDRA Life Sciences (NDRA) position steady in Q1 2026 at 51,900 shares worth $241K. The position accounts for 0.57% of the portfolio, ranked #19.

Altium Capital Management first reported a position in NDRA in Q4 2025 and has held it in 2 quarters since. 8 funds tracked by Wall St. Rank hold NDRA as of Q1 2026.

  • Altium Capital Management held 51,900 shares of ENDRA Life Sciences worth $241K as of Q1 2026.
  • Altium Capital Management left its ENDRA Life Sciences share count unchanged in Q1 2026.
  • ENDRA Life Sciences made up 0.57% of Altium Capital Management's portfolio in Q1 2026, its #19 holding.
  • Altium Capital Management first reported a position in ENDRA Life Sciences in Q4 2025 and has held it in 2 quarters since.
  • 8 funds tracked by Wall St. Rank held ENDRA Life Sciences as of Q1 2026.

Based on Altium Capital Management's 13F filing for Q1 2026, filed 1 May 2026.